HIGHLIGHTS
- who: . et al. from the Dalian Medical University, China have published the research work: The synergistic activity of SBC3 in combination with Ebselen against Escherichia coli infection, in the Journal: (JOURNAL)
- what: The authors report here that SBC3 can work synergistically with Ebselen to treat the five most difficult-to-treat Gram-negative bacteria. As a silver-based N-heterocyclic carbene, the authors propose that SBC3 could work with Ebselen in a similar manner.
- how: All the results showed that the treatment of SBC3 in combination with Ebselen displays strong bactericidal activity against . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.